Qualification work is focused on problematic of injuries, occurring in the population, and their influence regarding amount of costs covered by the public health care. The aim of this thesis is to determine, based on available information, expenses trends in health care and also costs, related to health care, of individual health insurance companies. Identification of injuries occurrence throughout the population and determination of their costs and complexity is furthermore important segment of the thesis. Based on these data, the objective of this thesis is to identify the portion of this amount contributing to the overall costs of public health care. The practical part of the thesis also contains analysis of recommendations, which might influence or cause change from current situation.

The purpose of this dissertation is to examine the organizational and environmental correlates of hospital EMR use and to examine the relationship between hospital EMR use and performance. Using a theoretical framework that combines resource dependence theory with Donabedian's structure, process, outcome model, a conceptual model is created. To test the hypotheses of this model, logistic regression and Data Envelopment Analysis (DEA) are used. The data included in this analysis come from the AHA, HIMSS, CMS, ARF, and HQA. In the analysis of hospitals correlates of EMR use, three hypotheses were supported, and one was partially supported. Hospital system affiliation, bed size, and environmental uncertainty were found to be positively associated with hospital EMR use. Hospital rurality was found to be associated with EMR use for all categories except one; at every other level of rurality, as the hospital moves on a continuum from least rural to most urban, the likelihood of hospital EMR use also increases. Hospital EMR use was not found to be associated with teaching status, environmental munificence, competition, operating margin, ownership, or public payer mix. In the hospital performance analyses, one hypothesis was supported, and one was partially supported. Regarding quality, hospitals with EMRs were found to provide higher quality than those without EMRs. In efficiency performance, only small hospitals with EMRs were found to be more efficient than hospitals without EMRs. No support was found that hospitals with EMRs improve their efficiency over time more than hospitals without EMRs. Hospital EMR use does vary by certain organizational and environmental characteristics. For this reason, hospitals and policy makers must take action that enables and encourages all hospitals to implement and use EMRs because some hospitals do not have the motivation or resources to begin using EMRs on their own. Hospital EMR use is positively associated with high quality care, thus justifying the practice. Hospital efficiency was not found to be associated with EMR use in medium or large hospitals, but it was found to be associated with EMR use in small hospitals. Interestingly, larger hospitals are more likely to use EMRs than small hospitals. It is possible that the efficiency gains of EMR use in hospitals will not be realized until a standardized, fully interoperable system is developed, allowing health care provides to quickly and easily share the medical charts of their patients.

Thesis (M.S.)--University of South Florida, 2007. / Title from PDF of title page. Document formatted into pages; contains 20 pages. Includes bibliographical references.

Diss. (sammanfattning) Stockholm : Karol. inst., 2006. / Härtill 5 uppsatser.

INTRODUÇÃO: Técnicas cirúrgicas de revascularização miocárdica sem o uso de circulação extracorpórea (CEC) trouxeram esperanças de resultados operatórios com menor dano sistêmico, menor ocorrência de complicações clínicas e menor tempo de internação hospitalar gerando expectativas de menor custo hospitalar. OBJETIVOS: Avaliar o custo hospitalar em pacientes submetidos à cirurgia de revascularização miocárdica com e sem o uso de CEC, em portadores de doença multiarterial coronária estável com função ventricular preservada. MÉTODOS: Os custos hospitalares foram baseados na remuneração governamental vigente. Foram acrescentados nos custos, o uso de orteses, próteses, complicações e intercorrências clinicas. Foram considerados o tempo e os custos da permanência na UTI e de internação hospitalar. Não foram consideradas remuneração de profissionais médicos e equipe multiprofissional, bem como depreciação de materiais, taxa de administração predial, água luz, telefone, alimentação, exames laboratoriais de admissão e medicamentos. RESULTADOS: Entre janeiro de 2002 a Agosto de 2006 foram randomizados 131 pacientes para cirurgia com CEC e 128 pacientes sem CEC. As características clínicas basais foram semelhantes para os dois grupos. Os custos das intercorrências cirúrgicas foram significantemente menores (p<0,001) para pacientes do grupo SCEC comparados ao grupo CCEC (606,00 ± 525,00 vs 945,90 ± 440,00) bem como, os custos na UTI (432,20 ± 391,70 vs 717,70 ± 257,70) respectivamente. Entretanto, o custo final foi maior no grupo SCEC (6.877,00 ± 525,20 vs 5.305,00 ± 440,11; p<0.001) devido ao preço do estabilizador utilizado. Os tempos de permanência na sala cirúrgica foram (4,9 ± 1,1h vs 3,9 ± 1,0h), (p<0,001), na UTI (48,25 ± 17,2h vs 29,20 ± 26,1h) (p<0,001), com tempo de entubação (9,2 ± 4,5h vs 6,4 ± 5,1h) (p<0,001) para pacientes do grupo com CEC e sem CEC respectivamente. CONCLUSÃO: Esses resultados permitem concluir que a cirurgia de revascularização miocárdica sem circulação extracorpórea, proporcionou diminuição de custos operacionais relacionados com a diminuição de tempo de permanência em cada setor do tratamento cirúrgico. Todavia, o alto custo do estabilizador, determinou o aumento do custo final da cirurgia SCEC. / INTRODUCTION: Techniques of coronary artery bypass grafting without the use of cardiopulmonary bypass (CPB) aim surgical results with less systemic damage, lower incidence of clinical complications and shorter hospitalization, generating expectations of lower hospital costs. OBJECTIVE: To evaluate the hospital cost in patients undergoing coronary artery bypass grafting with and without the use of CPB, in patients with multivessel coronary disease with stable preserved ventricular function. METHODS: Hospital costs were based on the current local government payment for the cardiac surgery. The use of orthoses, prostheses, and the clinical complications events were added in the cost. It was also added the duration of staying at ICU and total hospitalization period in the final cost. Yet, it was not considered remuneration of medical professionals as well as the cost of the depreciation of equipment, administration fee of land, water, electricity, phone, food, laboratory tests for admission and medicines. RESULTS: From January 2002 to August 2006, 131 patients and 128 patients were randomized for surgery with CPB and without CPB, respectively. The baseline characteristics were similar for both groups. The cost of surgical complications of the group without CPB were significantly lower compared to the group with CPB (606.00 ± 525.00 vs 945, 90 ± 440.00, p <0,001); as well as, the costs of ICU (432, 20 ± 391.70 vs 717.70 ± 257.70, p<0,001). Yet, the final cost was higher in the without CPB group (6.877,00 ± 525,20 vs 5.305,00 ± 440,11; p<0.001) due to the price of the Octopus stabilizer. Additionally, the occupation time at the operating room was (4.9 ± 1.1h vs 3, 9 ± 1.0h, p<0,001), at the ICU was (48.25 ± 17.2h vs 29, 20 ± 26.1h, p<0001) with intubations time (9.2 ± 4.5h vs 6, 4 ± 5.1h, p <0001) in the group with CPB and without CPB, respectively. CONCLUSION: These results showed that the coronary artery bypass grafting without cardiopulmonary bypass has decreased operational costs related to reduce length of stay in each sector of the surgical procedure. However, the high cost of the stabilizer lead to increased final cost of SCEC surgery.

OBJECTIVE: To estimate the resource costs of providing wound care for the 488,000 catchment population of the Bradford and Airedale primary care trust (PCT). METHOD: A wound survey was carried out over a one-week period in March 2007 covering three hospitals in two acute trusts, district nurses, nursing homes and residential homes within the geographical area defined by the PCT. The survey included information on the frequency of dressing change, treatment time and district nurse travel time. The resource costs of wound care in the PCT were estimated by combining this information with representative costs for the UK National Health Service and information on dressing spend. RESULTS: Prevalence of patients with a wound was 3.55 per 1000 population. The majority of wounds were surgical/trauma (48%), leg/foot (28%) and pressure ulcers (21%). Prevalence of wounds among hospital inpatients was 30.7%. Of these, 11.6% were pressure ulcers, of which 66% were hospital-acquired. The attributable cost of wound care in 2006-2007 was pounds 9.89 million: pounds 2.03 million per 100,000 population and 1.44% of the local health-care budget. Costs included pounds 1.69 million spending on dressings, 45.4 full-time nurses (valued at pounds 3.076 million) and 60-61 acute hospital beds (valued at pounds 5.13 million). CONCLUSION: The cost of wound care is significant. The most important components are the costs of wound-related hospitalisation and the opportunity cost of nurse time. The 32% of patients treated in hospital accounted for 63% of total costs. Putting in place care pathways to avoid hospitalisation and avoiding the development of hospital-acquired pressure ulcers and other wound complications are important ways to reduce costs. DECLARATION OF INTEREST: John Posnett is an employee of Smith & Nephew.

Tidigare forskning indikerar att individer med sömnapné får mer allvarliga skador i sambandmed vägtrafikolyckor jämfört med individer utan sömnapné. Det har även visats att merallvarliga skador genererar högre kostnader. Det finns dock ett kunskapsglapp i frågan om demer allvarliga skadorna som involverar individer med sömnapné har högresjukvårdskostnader i Sverige. Studier visar även att om patienter ska kunna få ut maximaltmed vård för de skattepengar som läggs på hälso- och sjukvården bör samhällseffektivakostnadsanalyser göras. En del i samhällseffektiva kostnadsanalyser är att identifiera,kvantifiera och värdera de kostnader som är relevanta vid ett specifikt olycksfall.Uppsatsens syfte är att framställa, jämföra och analysera de sjukvårdskostnader somuppkommer vid vägtrafikolyckor i Sverige orsakade av individer med och utan sömnapnéunder en uppföljningsperiod på ett, två och tre år. I sjukvårdskostnaderna inkluderas dekostnader som uppstår i slutenvården, öppenvården, samt läkemedelskostnader. Syftetuppfylls först genom identifiering, kvantifiering och värdering av sjukvårdskostnaderna. Meden ekonometrisk modell avser vi dessutom att förklara sambandet mellan de förklarandevariablerna ålder, kön och patientgrupp och den beroende variabeln sjukvårdskostnader. Denekonometriska modellen skapas utifrån data från olycksregistret Swedish Traffic AccidentData Acquisition (STRADA) och organisationen European Sleep Apnoea Database(ESADA).I resultatanalysen presenteras och analyseras sjukvårdskostnaderna utifrånsamhällsekonomisk teori för att avgöra om det existerar en skillnad i sjukvårdskostnader samtför att utreda hur den eventuella skillnaden är fördelad enligt Pareto- och Kaldor-Hickskriteriet. Studiens resultat visar på att det existerar en framträdande skillnad mellan de tvåpatientgruppernas sjukvårdskostnader. Marginalkostnaderna för patientgruppen medsömnapné är betydligt större än för patientgruppen utan sömnapné och de inkrementellakostnaderna visar också relativt stora kostnadsskillnader under respektive uppföljningsår. / Previous research indicates that individuals with the condition obstructive sleep apnoea(OSA) get more severe injuries after road traffic accidents, in comparison with individualswithout OSA. It has also, in previous studies, been shown that more severe injuries generatehigher costs. There is although a knowledge gap concerning whether the more severe injuriesthat involve individuals with OSA result in higher medical expenses. Furthermore, earlierresearch also implies that for patients to receive maximum healthcare from the tax moneyreimbursing the healthcare in Sweden, there should be socio-effective cost analysisconducted. An important part of socio-effective cost analysis is the identification,quantification and valuation of relevant costs associated with a specific causality.The aim of the study is to produce, compare and analyse the healthcare costs associated withroad traffic accidents in Sweden caused by individuals with and without OSA, during afollow-up period of one, two and three years. The healthcare costs include the costs that occurin the inpatient and outpatient care as well as pharmaceutical costs. The aim has been fulfilledthrough identification, quantification and valuation of the healthcare costs associated withroad traffic accidents, for individuals with and without OSA. In order to examine therelationship between the describing variables age, sex and patient group and the dependentvariable healthcare cost, we constructed an econometric model. The econometric model hasbeen assembled by data from the accident register Swedish Traffic Accident Data Acquisition(STRADA) and the organisation European Sleep Apnoea Database (ESADA).The result of the study presents and analyse the healthcare costs through socio-economictheory to decide whether there does exist a difference in healthcare costs and to investigate ifthe eventual difference in costs is distributed according to the Pareto- and Kaldor-Hickscriteria.The study’s result demonstrates a significant difference of the healthcare costs in thetwo patient groups. The marginal costs for the patient group with OSA is considerably higherthan the marginal cost for the patient group without OSA. The incremental costs also showrelatively large cost differences during the three follow-up years.

<p>Scaphoid fracture is most common in young individuals of working age. Without adequate diagnosis and treatment, long-term results are poor. Operative treatment is being recommended increasingly often instead of a long time in cast, although there is no evidence-based support for its superiority.</p><p>The present thesis focuses on diagnostic problems and therapeutic consequences of acute scaphoid fractures and of scaphoid reconstruction when other treatments have failed.</p><p>Simultaneous plain radiographs and computed tomography were done in 97 injured wrists. Structural assessments of plain radiography images were highly predictive with respect to the risk of having a displaced or comminute fracture as diagnosed on computed tomography. Any finding of a gap or step-off > 0.5 mm, the presence of an intermediate fragment or a dorsal lunate tilt of ≥ 15° identified 81 % of fractures that were displaced or comminuted when investigated with computed tomography.</p><p>Eighty-three patients were randomly allocated to and received either nonoperative treatment in cast or operative treatment with the aim of assessing long-term outcome of the two treatment options. Fifty-two of the patients were occupationally active. From an occupational perspective with an early return to work, surgical treatment was superior in individuals with manual employment, and from a health economic perspective conservative treatment was superior in non-manual workers.</p><p>Patients treated for scaphoid fractures generally do well up to 13 years after the injury based on limb-specific outcome scores. No benefits were identified with operative treatment compared to non-operative treatment in cast. On the contrary, there was an increased risk for osteoarthritis in the scaphotrapezial joint in those who were operated.</p><p>The patient-rated long-term results of silicone implant arthroplasty were good, with pain relief and reasonable hand function in many patients up to 20 years after surgery.</p>

<p>Hronična opstruktivna bolest pluća (HOBP) je rastući zdravstveni problem radno sposobne populacije. Akutne egzacerbacije hronične opstruktivne bolesti pluća (AEHOBP) značajno doprinose pogor&scaron;anju bolesti i sa aspekta kvaliteta života bolesnika i sa aspekta tro&scaron;kova. Cilj istraživanja je bila identifikacija faktora visokih tro&scaron;kova lečenja AEHOBP koja može pomoći u definisanju strategija smanjenja HOBP egzacerbacija ove bolesti i analiza podataka o prehospitalnom lečenju obolelih od HOBP. Materijal i metode: Istraživanjem je obuhvaćeno 130 pacijenata koji su ispunjavali uključujuće kriterijume studije. Rezultati: Ukupni godi&scaron;nji direktni tro&scaron;kovi hospitalizacija usled AEHOBP čine17,3% od tro&scaron;kova svih hospitalizovanih pacijenata. Prosečna dužina hospitalizacije je bila duža kod pacijenata sa te&scaron;kom AEHOBP u odnosu na srednje te&scaron;ku, razlika je statistički značajna (p = 0,044). Prema rezultatima istraživanja o potro&scaron;nji lekova godinu dana pre hospitalizacije, adekvatnu terapiju je koristilo 41,7% pacijenata, a neadekvatnu 58,3% pacijenata i postojala je negativna korelacija između adekvatnosti lečenja i stepena težine akutne egzacerbacije. Multivarijantnom logističkom regresijom dobijena je formula za predikciju ukupnih tro&scaron;kova. Zaključak: Nezavisni prediktori direktnih tro&scaron;kova lečenja su: mu&scaron;ki pol, pu&scaron;ačka navika, te&scaron;ka AEHOBP, postojanje acidoze, primena neadekvatne ili adekvatne terapije trajanja kraćeg od devet meseci tokom godine koja je prethodila hospitalnom lečenju egzacerbacije.</p> / <p>Chronic obstructive pulmonary disease (COPD) is a rising health issue of working population. Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are significantly contributing to worsening of the disease prognosis, consequently leading to decline of patient&rsquo;s quality of life and increasing costs of treatment. Objective of the study was identification of factors for high AECOPD treatment costs, which can help in defining strategy for decreasing COPD exacerbations and data analysis of prehospital treatment of COPD patients. Material and Methods: The study included 130 patients who fulfilled including criteria of the study. Results: Total direct costs of AECOPD hospitalizations demonstrated 17.3% of all hospitalized patients costs. Average length of hospitalization was longer in patients with severe AECOPD compared to patients with moderate AEHOBP, there was statistically significant difference (p= 0,044). According to research results of medication usage one year before the hospitalization, adequate treatment used 41.7% of patients, and inadequate 58.3%; there was negative correlation between adequate treatment and level of severance of acute exacerbations. Multivariate logistic regression was used for obtaining total costs predictions formula. Conclusion: Independent predictors of direct treatment costs were: male patients, smokers, prehospital treatment, inadequate or adequate, not longer than nine months per year.</p>

La question des coûts des soins de santé gagne en intérêt dans le contexte du vieillissement de la population. On sait que les personnes en moins bonne santé, bien que vivant moins longtemps, sont associées à des coûts plus élevés. On s'intéresse aux facteurs associés à des coûts publics des soins de santé plus élevés au niveau individuel, chez les Québécois vivant en ménage privé âgés de 65 ans et plus, présentant au moins un type d’incapacité. À l’aide de modèles de régression, la variation des coûts pour la consultation de professionnels de la santé et la prise de médicaments a été analysée en fonction du nombre d’incapacités ainsi que de la nature de celles-ci. Les informations sur l’état de santé et la situation socio-démographique proviennent de l’Enquête sur les limitations d’activités (EQLA) de 1998, celles sur les coûts du Fichier d’inscription des personnes assurées (FIPA) de la Régie de l’Assurance maladie du Québec (RAMQ), pour la même année. Les résultats montrent que les deux types de coûts considérés augmentent en fonction du nombre d’incapacités. D’autre part, des coûts plus élevés ont été trouvés chez les personnes présentant une incapacité liée à l’agilité concernant la consultation de professionnels de la santé, alors que, concernant la prise de médicaments, le même constat s’applique aux personnes avec une incapacité liée à la mobilité. Les deux types de coûts considérés présentent un niveau plus élevé chez les personnes présentant une incapacité liée au psychisme, en particulier lorsque l’on considère la prise de médicaments. Ces observations soulignent l’intérêt de considérer la nature du problème de santé lorsque l’on étudie les déterminants individuels du niveau des coûts des soins de santé. / The issue of healthcare costs becomes more pertinent in the current context of an ageing population. Despite the fact that elderly people in poor health do not live as long as those in good health, they are associated with higher healthcare costs. The purpose of this paper is to investigate the factors related to the variations of the public healthcare costs at an individual level, for non-institutionalized people of 65 years and older, living in the province of Quebec with at least one type of disability. Log-linear multiple regression models were performed, with physician consultations costs and medication costs as dependent variables. The number of disabilities an individual has, the type of disability, and the main socio-demographic confounders were chosen as independent variables. Information on these independent variables was taken from the 1998 survey Enquête Québécoise sur les Limitations d’Activités, and information on the dependent variables was taken from the dataset of Quebec’s public health insurance program from the same year. Both physician consultation and medication costs were found to be a function of the number of disabilities an individual has. Furthermore, those with an agility disability were linked to higher physician costs, while those with a mobility disability were found to have higher medication costs. Both costs were shown to be higher in the case of a psychiatric disability, which was shown to be particularly true for medication costs. These findings highlight the importance of taking into account the type of disability an individual has, when researching healthcare cost drivers.